ESTRO 2024 - Abstract Book

S4992

Physics - Radiomics, functional and biological imaging and outcome prediction

ESTRO 2024

Figure 2.

Conclusion:

Daily response monitoring with serial ADC measurements on a 1.5 T MR-linac for intermediate-risk rectal cancer needs to consider a repeatability coefficient of 21.5% in ADC changes to distinguish measurement variability from treatment response.

Keywords: ADC, Rectal cancer, MRgRT

819

Digital Poster

Development of an explainable AI Model for OS prediction in LA-NSCLC patients receiving RT

Zhen Zhang 1,2 , Leoanrd Wee 2 , Andre Dekker 2 , Ji Zhu 1 , Lujun Zhao 3

1 Zhejiang Cancer hospital, Radiation Oncology, Hangzhou, China. 2 GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Radiation Oncology, Maastricht, Netherlands. 3 Tianjin Medical University cancer hospital, Radiation Oncology, Tianjin, China